Trend of rifampicin resistant, MDR and XDR tuberculosis in Italy, 2009–2016
- Lanfranco Fattorini*
- *Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
- ¶Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan, Italy
- §A full list of the SMIRA group members and their affiliations can be found in the Acknowledgement section
- Dr Lanfranco Fattorini, Department of Infectious Diseases, Istituto Superiore di Sanità, Via Regina Elena 299, 00161 Rome, Italy. E-mail: lanfranco.fattorini{at}iss.it
Abstract
In Italy, rifampicin-resistant and MDR-TB were high in foreign-born persons, but decreased from 2009 to 2016
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Mustazzolu has nothing to disclose.
Conflict of interest: Dr. Borroni has nothing to disclose.
Conflict of interest: Dr. Giannoni has nothing to disclose.
Conflict of interest: Dr. Iacobino has nothing to disclose.
Conflict of interest: Dr. Fattorini has nothing to disclose.
Conflict of interest: Dr. Cirillo has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©ERS 2018